SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (3770)2/8/1998 1:03:00 PM
From: JOHN W.  Read Replies (1) of 6136
 
"HIV Drugs Credited for Saving Lives in New York"
Reuters (02/05/98)
At the Fifth Conference on Retroviruses and Opportunistic
Infections Mary Anne Chiasson of the New York City Department of
Health reported that AIDS deaths in the city fell by 30 percent
between 1995 and 1996. The decline was attributed to the
increased availability of protease inhibitors. A research team
led by Chiasson followed 150 AIDS patients who died during 1996
and 150 who did not die, and found that 10 percent of those who
died had taken protease inhibitors, versus 32 percent of those
who lived.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News